Boston Scientific gets FDA warning

Boston Scientific Corp. sent potentially defective medical devices to several hospitals because its quality-control system allowed them to slip out of designated quarantine areas, according to a warning letter from the Food and Drug Administration released yesterday. (Full article: 631 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly